Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich Plasma for Chronic Anal Fissure
NCT05837403Phase 3Completed
- Sponsor
- Al-Kindy College of Medicine
- Start
- Oct 2020
- Primary completion
- Jul 2022
- Modality
- Hydrogel Systems, Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of autologous platelet rich gel in anal fissure, sponsored by Al-Kindy College of Medicine. Primary endpoint: Healing of fissure at 3 months. Started Oct 2020; status: completed.
02
Drugs
autologous platelet rich gel
03
Conditions
anal fissure
Beyond the preview
Go deeper on NCT05837403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05837403.